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Abstract
Stress-induced  alterations  in  sleep  have  been  linked  to  the  development  of  post-
traumatic stress disorder (PTSD) and sleep complaints and disturbances in arousal are
continuing symptoms in patients. PTSD-related changes in sleep have not been fully
characterized but involve persistent disturbances in both rapid eye movement sleep
(REMS) and non-rapid eye movement sleep (NREMS). PTSD is considered a disorder
of the fear circuitry, which includes the amygdala, dorsal anterior cingulate, hippocam-
pus, and ventromedial prefrontal cortex. Currently, several animal models are used to
examine the underlying neurobiology of PTSD; however, sleep has been characterized
in only a limited number of models. Intense conditioned fear training, which may best
model PTSD in rodents,  can produce reductions in REMS as well as alterations in
NREMS that may vary with mouse and rat strains. The amygdala, a central region in
current concepts of PTSD, plays significant roles in regulating the stress response and
changes in stress-induced alterations in arousal and sleep. This chapter reviews sleep-
related findings in patients with PTSD and in animal experimental paradigms currently
utilized to model the disorder, as well as the neurobiology that has been linked to
disturbed sleep in PTSD. It will also discuss the impact of PTSD treatments on sleep
disturbances.
Keywords: amygdala, animal models, conditioned fear, rapid eye movement sleep,
stress
1. Introduction
Post-traumatic stress disorder (PTSD) is a neuropsychiatric disorder which develops in a
significant subset of the population following psychological trauma. It is estimated that 70%
of individuals will experience a traumatic event sometime in their lifetime; however, only an
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estimated 20% of those who experience significant trauma will go on to develop PTSD. Sleep
complaints and disturbances in arousal are continuing and distressing symptoms in PTSD and
stress-induced alterations in sleep have been linked to the development of PTSD. However,
the exact role sleep plays in PTSD is unknown. This chapter will describe our current under-
standing of disturbed sleep in PTSD patients, how sleep is altered in animal models employed
to study PTSD, linkages between the neurobiology of PTSD and sleep regulation, and current
therapies for treating sleep disturbances in PTSD. Our review will discuss the complex effects
of stress on sleep, stress parameters that appear to be important in determining post-stress
sleep, and the neuroanatomical substrates important in regulating the relationship between
stress and sleep. Lastly, we will discuss some of the limitations that need to be addressed in
order to advance our understanding of the role that sleep may play in PTSD.
2. Sleep in PTSD patients
PTSD is unique among mental disorders in that a disturbance of sleep is included twice among
the diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
[1]—as recurrent nightmares, a re-experiencing symptom, and also as insomnia, a symptom
of hyperarousal. By self-report, 52–96% of individuals with PTSD have endorsed experiencing
frequent nightmares [2, 3] while insomnia is reported by up to 70% of individuals with PTSD
[4]. Unmentioned in the DSM-5, but well recognized by clinicians and PTSD patients alike, is
excessive, disruptive movement during sleep [5].
In recent years, much has been learned about the clinical phenomenology and pathophysiology
of PTSD, including the sleep disturbances. However, there have been remarkably few studies
of the optimal approaches to treating the recurrent nightmares and insomnia that are so
prevalent in the disorder and represent two of its major morbidities. We proceed to provide a
description of the sleep disturbances experienced by individuals with PTSD, the brain
mechanisms implicated by clinical studies, and the treatments, both psychotherapeutic and
pharmacological, that have been proposed.
Largely because nightmares occur during rapid eye movement sleep (REMS) and are a
distinguishing symptom of only PTSD, among all mental disorders, we (RJR; [5]) originally
proposed that REMS mechanisms are essential to the pathophysiology of disturbed sleep in
PTSD. At the same time dreams, albeit less vivid and more thought-like than nightmares, also
emerge from non-REMS (NREMS) and as such a role of NREMS mechanisms must also be
considered. The extant polysomnographic (PSG) literature provides no firm consensus
regarding defining sleep abnormalities in PTSD. Enhanced, fragmented, and preserved REMS
all have been reported [6–9]. Mellman et al. [10] have emphasized the likely importance of the
duration of time following the trauma as an explanation of the diverse PSG findings in PTSD.
In a non-clinical community sample of young adults assessed retrospectively by patient
interview, both REMS percentage (amount of time spent in REMS/total sleep time) and average
REMS segment duration were positively correlated with PTSD chronicity [10]. In addition,
REMS latency (time from sleep onset to the start of the first REMS episode of the sleep period)
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was negatively correlated [10]. These findings point to a view of PTSD pathogenesis in which
REMS plays a prominent role, as a biomarker or perhaps as a central etiologic element.
Mellman et al. [10] suggested that increases in REMS percentage and continuity that occur over
time post-trauma could indicate a role of REMS in promoting adaptation to, and recovery from,
trauma. While acknowledging that this hypothesis fits well with independent evidence that
REMS processes help in the processing of emotional memories, we (RJR; [11]) have suggested
that the reconstituted REMS observed long after traumatization may be pathological and, in
fact, a sign of poor adaptation to a severe stressor. In a psychoanalytic framework, the repeating
traumatic dream would be an indication of the failure of the normal dream mechanism.
An increase in REMS continuity with the passage of time following trauma warrants consid-
eration in the context of the extant PTSD treatment literature. The alpha-adrenoceptor
antagonist prazosin is arguably the most effective pharmacotherapy for recurrent post-
traumatic nightmares. Although PSG has not been carried out in most prazosin trials, Taylor
et al. [12] reported that the drug increased total REMS time and average REMS episode
duration in a civilian group with PTSD. This suggests that prazosin’s therapeutic effect may
depend on a normalization of REMS continuity. Pharmacotherapy for PTSD will be reviewed
at greater length below.
Understanding the dynamics of REMS changes after exposure to a traumatic stressor must
account for phasic as well as tonic REMS processes. REM density (number of rapid eye
movements/REMS time) is the phasic REMS measure most often reported in clinical investi-
gations. In a meta-analysis of 20 PSG studies of PTSD, an increased REM density was the
strongest finding [13]. An emphasis on heightened REM density in PTSD is consistent with
the early observation of a direct relation between rapid eye movement activity and the intensity
of dream mentation in healthy subjects [14].
A greater frequency of phasic leg muscle twitches (calculated as the percentage of REMS
epochs with at least one prolonged tibialis anterior twitch; REMS phasic leg activity (RPLA)
index) also has been described in PTSD [15]. Although no clear association between RPLA and
rapid eye movement activity was seen overall, a single recorded nightmare occurred out of a
REMS episode with a particularly high REM density. This observation led to the hypothesis
that, as a nightmare unfolds, diverse REMS phasic processes, which can otherwise be uncou-
pled, may be recruited en masse [15].
Largely because investigations in animals have implicated REMS phasic activity in the
processing of fearful stimuli [16, 17], it is important to consider the possibility that severe
psychological stress initiates processes in REMS phasic event generators that promote
adaptation to trauma, or, alternatively, maladaptation in the form of PTSD. Studying fear
conditioning in rats, DaSilva et al. [18] proposed that failure to mount a strong phasic REMS
response in the early aftermath of a stressful experience could predispose individuals to the
increase in REMS phasic activity that has been observed in humans with chronic PTSD.
PTSD is very often comorbid with other mental disorders, most commonly depression [19]. In
addition, new to the criteria for diagnosing PTSD is a set of symptoms, including low self-
worth and anhedonia, classed as “negative alterations in cognition and mood” [1]. This raises
Sleep Disturbances in PTSD
http://dx.doi.org/10.5772/64189
19
the question whether REMS abnormalities that have been described in PTSD are in fact a
function of depression, for which heightened “REMS pressure” (analogous to increased REMS
continuity in evolving PTSD), is the best characterized PSG finding [20].
In order to clarify the distinct roles of PTSD and depression in the REMS changes observed
after psychological traumatization, Ross et al. [9] analyzed PSG data by thirds of the night and
found increases in REMS percentage and REM density throughout the sleep period in a group
of military veterans with chronic combat-related PTSD. These distributions were distinguished
from shifts in REMS amount and REM number to earlier in the night, which characterize major
depressive disorder [20]. Supporting the importance of brain mechanisms fundamental to
PTSD in mediating REMS changes following traumatization, Mellman et al. [10] found that a
positive correlation between REMS percentage and time elapsed following traumatization
remained significant after excluding subjects with comorbid major depression. Nonetheless,
the current emphasis by the National Institutes of Health on Research Domain Criteria (RDoC)
in neurobehavioral research provides an alternative perspective, in which both PTSD and
depression can be conceptualized as disorders of “dysphoric hyperarousal,” sharing in
elements of a common REMS pathophysiology.
3. Stress, sleep, and PTSD animal models
By definition, stress is a significant component of putative animal models of PTSD. However,
experiments in animals have shown that virtually any stressful experience can significantly
impact subsequent sleep [21]. Exposure to many experimental stressors induces a period of
arousal [22] followed by subsequent rebound sleep (increases in REMS and/or NREMS) that
occur at various latencies after the stressor is removed. REMS appears to be particularly
susceptible to the effects of stress and can either be decreased or increased depending on
stressor characteristics, for example, controllability [23, 24] or possibly individual resilience or
vulnerability to stress [25].
Sleep disturbances, both before [26] and after [27, 28] a traumatic event, may be predictive of
future development of emotional and physical disorders. This suggests that stress-induced
sleep alterations in animal models may be critical for assessing their value for examining
underlying neural mechanisms that produce long-term pathological alterations in behavior as
well as for understanding the linkage between stress and continuing sleep disturbances in
PTSD. Unfortunately, current efforts are hampered by a lack of full understanding of altera-
tions in sleep associated with traumatic events that lead to PTSD. There also is relatively limited
work examining sleep in animal stress models as well as an incomplete understanding of what
those stress-induced alterations indicate with respect to successful or unsuccessful coping with
stressful events. That is, although stress can have a significant, long-lasting negative impact
on health, stressors are commonly encountered in daily life without producing permanent or
pathological changes, and the majority of individuals cope with traumatic life events with only
transitory effects. Many of the stress models that have been explored produce differences in
subsequent sleep, as illustrated in the models discussed below; however, their actual relevance
to PTSD, for the most part, is not known.
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3.1. Fear conditioning stress
PTSD is viewed as a disorder of the brain’s fear system [29]. As such, experimental fear
conditioning is a leading experimental model of processes thought to be related to PTSD as it
allows exploration of learned fear and anxiety in animals [30–35]. Fear conditioning occurs
when a neutral stimulus or context becomes associated with the occurrence of a significant
aversive emotional event; subsequently, those previously neutral stimuli and contexts alone
can elicit behavioral and physiological fear responses similar to those induced by the aversive
event itself. During training, animals are exposed to an aversive stimulus (unconditioned
stimulus; US (usually footshock)) in experimental paradigms that utilize various numbers of
trials, shock intensities, and durations. For cued fear conditioning a tone or light is utilized
(conditioned stimulus; CS) to alert the animals to the shock. Contextual fear conditioning does
not alert the animal to the shock and as such the animal simply associates the context (also a
CS) with the shock. After training, the cued or contextual CS elicits physiological and behav-
ioral response (conditioned response; CR) similar to those produced by the US. The animal
can be tested for fear memory by presenting the CS and measuring the CR.
Fear conditioning models are particularly relevant for PTSD as they can engage fear memory
processes without requiring a full re-experiencing of the stressful event. These paradigms are
also valuable because they allow stressor parameters (e.g., duration, intensity, controllability)
to be manipulated and allow fear memory processes to be assessed and manipulated. They
have been highly used for explorations of the relationship between fear memory and sleep.
However, it is important to note that conditioned fear also can underlie adaptive behavior that
typically is extinguished when the fear-inducing situation is removed. Fear “extinction”
learning creates a new memory that inhibits subsequent fear without erasing the original
memory for fear conditioning [36]. It is the failure of extinction that has been linked to
persisting symptoms of PTSD [37]. The effects on sleep of stress, conditioned responses, and
extinction in paradigms related to fear conditioning are discussed below.
3.1.1. Footshock stress
Footshock has been utilized as a stressor in models relevant to anxiety and depression, as well
as specifically to PTSD. Like some other stress models, the effects on sleep vary with stressor
parameters as well as the putative resilience and vulnerability of the animal receiving the
stressful experience.
A variety of studies have demonstrated enhanced REMS in rats [38–42] and mice [43] (and rats
also denser ponto-geniculo-occipital (PGO) waves, a signature characteristic of REMS [38]) at
various latencies after shock avoidance training in a shuttle box. In the avoidance paradigm,
animals are signaled of imminent shock and can learn to jump to safety without shock ever
being delivered. The increases in REMS have typically been viewed in the context of learning
and interpreted as indicating a role for REMS in memory consolidation, but there is potential
significant stress as the learning is motivated by footshock.
By comparison, Adrien et al. [44] in an early study using an extensive inescapable shock (IS)
paradigm (60 footshocks of relatively high intensity (0.8 mA) and duration (15 s)) found greater
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REMS latency, reduced REMS and increased light NREMS compared to the control group and
their own baseline sleep. Afterwards, REMS returned to control amounts, but no REMS
rebound was observed in recordings that night or the following day. We have also conducted
studies utilizing extensive shock training in mice and failed to observe a REMS rebound over
ten days of post-training recording [45]. This lack of recovery REMS is different than most
other forms of stress (including water maze, exposure to novel objects, open field, ether
exposure, cage change, and some types of social stress), which cause an initial REMS decrease
followed by an increase (rebound) later during the recording period (reviewed in [21, 125]).
One of the significant differences between typical IS training used for fear conditioning and
avoidance training is that animals can learn to totally avoid receiving shock. We have utilized
a yoked footshock paradigm in which animals receive identical amounts of footshock, but one
of a pair can learn an escape response (simply moving to the safe side of a shuttle box) whereas
the yoked animal cannot. Escapable footshock (ES) can produce significant increases in REMS
whereas IS can produce significant decreases in REMS (with variable changes on NREMS) [23,
24, 46]. Changing the paradigm (e.g., signaling the footshock) can modify subsequent sleep
after ES [47].
Together, these studies indicate that the type of environmental information available to the
animal, and the associated learning, are important factors in the effects of footshock stress on
REMS. They also suggest that these factors can be manipulated to produce either increases or
decreases in REMS, and potentially enable assessment of the role that REMS may have in
mediating the effects of stress.
3.1.2. Fearful reminders
It is believed that PTSD patients have impaired contextualization, the inability to appropriately
contextualize the traumatic events in autobiographic memory. That is, PTSD patients are
unable to process traumatic experiences as time and context limited events. Therefore, it is
beneficial to use a model which not only has a physical trauma (e.g., shock) but also enables
probing memories of stressful events. Critically, evoking memories of shock training can
produce alterations in sleep similar to those produced by the shock experience itself. That is,
cues or contextual reminders of footshock training experiences that decrease REMS also
decrease REMS (in mice [45, 48, 49] and rats [50–54]) whereas reminders of footshock training
experiences that increase REMS also can increase REMS [23, 24, 46]. These directionally
different alterations in sleep can occur even though behavioral freezing (the gold standard CR
for measuring fear in this paradigm) is virtually identical for both reminders that decrease
REMS and those that increase REMS. Pawlyk et al. [54] also showed that cue exposure at day
14 following IS training produced greater freezing than cue exposure on day 1 suggesting that
the fear memory can strengthen over time.
3.1.3. Extinction
PTSD patients are generally deficient at learning that stimuli previously associated with
adverse outcomes no longer produce a threat. As such prolonged exposure (PE) therapy is
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utilized to help change the processing of the fearful memory trace (for full description see
Section 5.1 in this chapter). In the laboratory, the extinction paradigm is utilized to assess
changes in behavior and sleep related to creating a new stronger memory to the previously
fearful cue or context. As such, the animals are exposed to the US until they no longer show
the CR (typically freezing). We have shown that extinction training is followed by increased
REMS (beyond baseline levels) [55]. Furthermore, if the extinction training is unsuccessful, the
negative effects on sleep and overt behavior will continue. Work in other laboratories has also
found positive correlations between extinction and sleep [16].
3.2. Single prolonged stress (SPS)
SPS has been argued to be an appropriate model for simulating the chronic stress conditions
potentially experienced by military personnel. In the SPS model, the animal experiences 2 h of
restraint immediately followed by 20 m of forced swim and, after an additional 15 m, exposure
to ether until unconsciousness. The SPS model does produce, in animals, increased fast
negative feedback of the hypohypothalamic–pituitary–adrenal (HPA) axis [56] and enhanced
contextual fear [57] similar to patients with PTSD. Furthermore, following SPS, rats show
increased percentage of REMS, increased transitions to REMS, and increased wakefulness
during the dark period [58].
Upon subsequent exposure to mild cued fear conditioning, the SPS animals showed impair-
ment to extinction recall compared to the control animals [58, 59]. Unfortunately, sleep
alterations associated with fear conditioning and extinction were not recorded, so it is
unknown what effect prior SPS and fear conditioning together have on subsequent sleep.
3.3. Immobilization stress
Immobilization stress has been utilized to study processes thought involved in PTSD. Con-
ceptually, immobilization is argued to generate PTSD-like anxiety as it involves the animal
(mouse or rat) being restrained for an unknown period of time. It can produce both behavioral
anxiety and increased negative HPA feedback which are seen in patients with PTSD [60].
Additionally, the timing can be altered from relatively mild (1 h) to extensive (20 h) and acute
(1 time) to chronic (across several days) exposure. With a short period of acute immobilization
(1–2 h) during the light period, NREMS is increased while REMS may be initially decreased
but ultimately increased over the dark period [61–63]. A much more extensive immobilization
lasting 20 h a day for 4 days in rats decreased both NREMS and REMS [64]. When the immo-
bilization was conducted for 1 h at the start of the dark period, NREMS and REMS were
increased during various phases of the dark period in rats [65–67]. Using rats, Marinesco et al.
[68] compared 1, 2, and 4 h immobilization at the beginning of the dark period and found
different effects for each duration including no change in sleep following 4 h of restraint. Other
authors have also found differences in the effects on sleep depending on when immobilization
was experienced [47]. Thus, the duration of immobilization, the acute or chronic nature of the
stressor, and the time of the circadian cycle are important for its effects on subsequent sleep.
It is not clear which, if any, of the changes in sleep model those occurring in PTSD. Immobili-
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zation also does not simulate the situational reminders that often produce symptoms in
patients with PTSD.
3.4. Limitation of models
One of the critical problems in studying the effects of stress on sleep in animals with respect
to modeling the development of PTSD is the lack of a clear understanding of the nature of the
alterations in sleep that are associated with the development of PTSD as opposed to those
associated with a normal, and therefore non-pathological, stress response. As noted above,
virtually all stressors produce alterations in sleep and it is highly unlikely that all reflect
pathological processes. It is also not known whether the initial stress-induced alterations in
sleep are the same as those that occur in later stages of PTSD or how they may be modified
over time by subsequent life experiences. In addition, work in animals has generally focused
on acute stress manipulations and their immediate or near-term effects on sleep. Potential
longer-term changes in sleep and their relationship to behaviors indicative of PTSD have
received much less attention.
Genetic differences are an important factor in the development of stress-related pathology as
approximately 20–30% of individuals who experience traumatic events may develop PTSD
[69, 70]. A few attempts to develop animal models that better represent individual differences
in clinical populations have included selecting low and high responders to stressors in outbred
rat strains [69–71]. However, the potential role of individual differences in resilience and
vulnerability has been minimally explored, particularly in studies that involve sleep. The
potential differences in sleep among those who develop PTSD and those that adequately cope
with significant stress are not known. We have demonstrated that mouse strains that exhibit
greater anxiety-like behaviors in response to challenges in wakefulness also show greater and
longer duration alterations in sleep after training with inescapable shock and after fearful cues
[48] and contexts [72]. Recently, we have also found significant individual differences in stress
and conditioned changes in sleep within outbred Wistar strain rats [25].
Thus, significant limitations in animal models of sleep disturbances in PTSD arise from an
imperfect understanding of which stressful experiences can lead to persisting psychopathol-
ogy, how those may interact with individual differences in resilience and vulnerability, and of
the role that sleep may play in adaptive coping with stress. These factors suggest that
refinement is needed in the way that stress and sleep are studied if truly successful models are
to be developed.
4. Neurobiology linking fear and sleep
In order to identify and compare circuitry in normal versus pathological fear responses in
humans, cued fear conditioning paradigms are utilized in conjunction with brain imaging. As
such, activity within the amygdala, hippocampus, ventromedial prefrontal cortex (vmPFC),
and dorsal anterior cingulate cortex (dACC) have been identified as key structures for fear
conditioning as well as being central to current concepts of PTSD neurobiology.
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4.1. Normal fear circuitry
Amygdala activity is especially important for fear expression and extinction [73–78]. During
reversal training, different subnuclei of the amygdala have been implicated related to asso-
ciational and attentional processes [79]. The hippocampus has been linked to the contextual
features associated with fear conditioning and expression and hippocampal activity has been
observed during fear behavior in several imaging studies [78, 80–82]. The hippocampus is also
implicated in extinction training and recall of extinction [82, 83]. Activity in the vmPFC has
been shown to be decreased during acquisition and expression of fear and increased during
extinction of fear behavior and recall of extinction [77]. Conversely, dACC is increased during
fear acquisition and expression [75, 77, 82]. The amygdala, hippocampus, vmPFC, and dACC
are functionally connected during fear expression, whereas just the amygdala, hippocampus,
and vmPFC are functionally connected during fear extinction.
It is important to note here that two of the regions involved in the circuitry of normal fear, the
amygdala and mPFC, are also involved in modulation of sleep. Neuronal activity of amygdala
varies across the sleep-wake states, with increased activity during REMS and less activity
during NREMS compared to wakefulness [84, 85]. It is also interconnected with wakefulness
promoting and sleep promoting areas throughout the brain. Regions of mPFC also have
interconnections with sleep-promoting regions and may be involved in modulation of sleep
following fear conditioning. In fact, a recent study found vmPFC activity during fear condi-
tioning was positively correlated with subsequent REMS [86].
4.2. Fear circuitry alterations in patients with PTSD
Imaging studies have found structural abnormalities in fear neurocircuitry, specifically in the
dACC, amygdala, and hippocampus in patients with PTSD [87, 88]. Furthermore, this
neurocircuitry appears to be activated inappropriately in patients with PTSD. In one study,
when asked to recollect traumatic events, PTSD patients had decreased activity in the vmPFC
and increased activity in the amygdala compared to controls (reviewed in [89]). This finding
was replicated using a task that had presentation of fearful faces [89, 90]. In another experiment,
patients with PTSD showed normal extinction learning, but exhibited impaired extinction
retention accompanied by increased activation of dACC and decreased activation of hippo-
campus and vmPFC [83]. It has been suggested that persistent fear in PTSD patients is due to
hyperactivation of amygdala and dACC and hypoactivation of vmPFC and hippocampus [83,
91, 92]. This hyperresponsivity of the amygdala to threat-related stimuli may be combined
with inadequate top-down governance by the vmPFC leads to hyperarousal and deficits in
extinction learning/recall [89].
4.3. Insight from animal models
The amygdala, mPFC, and hippocampus have established roles in fear conditioning and
fear extinction (e.g., [37, 93]) as well as being central to current concepts of PTSD (e.g.,
[94]). Of these regions, the amygdala has a recognized role in regulating fear- and stress-
induced alterations in sleep, especially REMS [53, 95, 50] as well as in the acquisition and
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consolidation of fear conditioning (e.g., [96–102]). In addition to its roles in mediating fear
memory and fear responses, the amygdala is important in the regulation of behavioral,
physiological, and neuroendocrine responses to stress [103–105] and it appears to be a vital
interface between stressful events, stressful memories, and their impact on sleep and arous-
al.
The amygdala has a strong influence on REMS (e.g., [106–110]), which can be significantly
altered by stress [48, 111, 72]. However, there is also evidence that the amygdala can influence
all sleep-wakefulness states [107, 109, 110, 112]. This influence most likely involves amygdalar
projections to thalamic, hypothalamic, and brainstem target regions [113] that are involved in
the control of sleep and arousal. These include direct projections via the central nucleus of the
amygdala (CNA; e.g., [114–118]) and the lateral division of the bed nucleus of the stria
terminalis (reviewed in [113, 119]), the sources of the major descending outputs of the
amygdala to brainstem regions linked to the regulation of REMS.
The functional role of the amygdala in mediating the effects of stress on sleep has been
demonstrated. For example, blocking inactivation of the CNA with microinjections of gamma-
aminobutyric acid (GABAA) antagonist, bicuculline, immediately following IS can eliminate
the reduction in REMS commonly seen following IS [95]. Moreover, blocking inactivation of
CNA can alter brain activation, as indicated by c-Fos (a marker of neuronal activity) in a
manner consistent with the reduced effect on REMS. That is, there was a reduction in c-Fos
activity in the locus coeruleus (LC), an area implicated in the regulation of REMS [120],
consistent with enhanced REMS. By comparison, inactivation CNA with microinjections of
the GABAA agonist, muscimol, did not significantly alter the reduction of REMS or c-Fos
activation in LC that can be produced by IS.
In addition to its role in the acquisition and consolidation of fear conditioning (e.g., [96–102]),
the basolateral nucleus of the amygdala (BLA) also appears to be critical for determining how
and whether fear memories impact sleep. For example, the corticotropin-releasing factor
antagonist, antalarmin, administered into BLA of rats prior to IS training blocked both IS-
induced reductions in REMS and the formation of memories that alter sleep without blocking
fear memory as indicated by contextual freezing [53]. By comparison, global inactivation of
BLA with microinjections of muscimol prior to IS blocked the post-training reduction in REMS
seen in vehicle-treated rats and attenuated contextual freezing and subsequent reductions in
REMS [121]. Together, these data indicate that BLA plays a significant role in regulating the
initial effects of stress and fear on sleep and in mediating the subsequent effects of fearful
memories.
Stressor controllability is an important determinant of the effects of stress and stress-related
memories on sleep. The mPFC is a critical region in the perception of control and in mediating
the consequences of stress [122–124]. For example, blocking activation of the vmPFC with
muscimol in rats presented with escapable shock produced failure in escape learning and
greater fear conditioning [124]. By comparison, activation of vmPFC with picrotoxin, a
GABAA antagonist, prior to IS promoted later escape learning in rats provided an opportunity
to escape shock in a shuttle box [124].
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Unfortunately, the role of the mPFC in mediating the effects of stressor controllability on
sleep has not been examined. However, part of the influence of mPFC [124] is enacted
through its effects brainstem regions that play roles in modulating REMS [120] as well as in
the stress response (reviewed in [125]), thereby providing a potential substrate for regulat-
ing the effects of stress on REMS. There also are projections to the BLA and CNA and pro-
jections to GABAergic neurons in the intercalated nuclei, which have inhibitory control
over CNA output [126]. Thus, projections from the mPFC to brainstem regulatory regions
and the amygdala provide a substrate by which stressor controllability could influence
REMS.
5. Clinical treatment
Studies of the first-line treatments of PTSD, both psychotherapeutic and pharmacological, have
rarely examined the effectiveness of these therapeutic modalities for PTSD-related sleep
symptoms. This is especially concerning given the evidence for clinically significant residual
sleep problems during and following PTSD treatment [127, 128]. In addition, persistent
insomnia and recurrent nightmares can compromise treatment responses to empirically
supported PTSD interventions.
5.1. Psychotherapy
The most widely accepted psychotherapies for PTSD are cognitive behavioral treatments
(CBTs) and include PE and cognitive processing therapy (CPT) [129]. Galovski and colleagues
[130] found that both PE and CPT were effective in reducing global sleep disturbance in adult,
female rape survivors; however, sleep impairment remained clinically significant in both
groups despite an overall improvement in PTSD symptoms. Gutner and colleagues [128]
examined the long-term effects of CPT and PE on sleep disturbance. Similar to previous
studies [130, 131], they found significant improvements in waking PTSD symptoms but no
remission of the sleep disturbance.
CBT for insomnia (CBT-I) is a brief intervention aimed at improving overall sleep quality [132,
133]. It includes instruction in stimulus control (in order to reduce negative associations with
the bed and bedroom) and sleep restriction (in order to increase sleep drive by first limiting,
and then gradually raising, the amount of time allowed in bed); cognitive restructuring (to
identify and challenge inaccurate beliefs that interfere with sleep); education in sleep hygiene;
and relaxation training (to minimize physical and mental tension around sleep onset) [132,
134].
CBT-I may be beneficial for insomnia in PTSD. In a randomized clinical trial (RCT) of CBT-I
compared to a waitlist control in a community sample in treatment for PTSD, the CBT-I group
had a superior response on measures of sleep amount and quality [135]. However, both groups
reported reductions in PTSD symptom severity and post-traumatic nightmares, limiting any
conclusions that can be drawn about the therapeutic elements of CBT-I specifically.
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Imagery rehearsal (IR) [136–138] is a form of CBT that targets recurrent nightmares. There
is evidence that it promotes increased mastery of nightmare content and experience [139].
IR protocols share the following basic steps: choosing a repetitive nightmare, rescripting it
during waking, and imaginally rehearsing the new dream script at bedtime. Two recent
meta-analyses of predominantly uncontrolled trials of IR reported large effect sizes for
nightmare frequency and sleep quality as well as overall PTSD symptomatology [137, 140].
However, a RCT in Vietnam War veterans with chronic, severe PTSD suggested that IR
may hold no advantage over a comparison treatment with elements of CBT-I [141]. In a
meta-analysis of studies of CBT-I combined with IR, a large gain in sleep quality was re-
ported, but there was no significant improvement in PTSD severity and the nightmare dis-
turbance [140].
5.2. Pharmacotherapies
The selective serotonin reuptake inhibitors (SSRIs) have the strongest evidence base among
pharmacotherapies for PTSD [142, 143]. The use of selective norepinephrine-serotonin
reuptake inhibitors (SNRIs), in particular venlafaxine, is also supported by clinical guidelines
[142]. However, there is little evidence that insomnia and recurrent nightmares in PTSD
respond to either the SSRIs or the SNRIs.
The tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) have not been
studied in large RCTs in PTSD [144]. There is only weak support for the usefulness of
these classes of psychotropic medication in controlling recurrent nightmares [145]. Consid-
ering the prominent REMS suppressant effect of the MAOIs and the evidence that most
nightmares emerge from REMS, a methodical investigation of the MAOIs is warranted
[145].
The atypical antipsychotic drugs have been minimally studied as a treatment for PTSD. One
small placebo-controlled trial of adjunctive olanzapine for combat-related PTSD non-respon-
sive to an SSRI found a greater improvement in sleep, as measured by the Pittsburgh Sleep
Quality Index [146]. However, a larger study in veterans showed no significant effect of
adjunctive risperidone [147]. There have been no completed RCTs of other medications in this
class.
Little is known about the treatment of insomnia in PTSD with benzodiazepines, commonly
used to treat other forms of insomnia [148]. Clonazepam, the mainstay of pharmacological
treatment for REMS behavior disorder, could have a role in managing excessive movement
during sleep in PTSD, a topic for future research. One RCT of the non-benzodiazepine receptor
agonist eszopiclone reported greater improvements in PTSD symptoms including sleep
disturbance [149].
As noted above, there is strong support for the alpha-1 adrenocepter antagonist prazosin as a
treatment for the nightmare disturbance in PTSD. Four placebo-controlled trials of prazosin,
two in veterans, one in active-duty US service members, and one in civilians, support its
efficacy [12, 150–152]. Prazosin must be administered continuously to avoid the recurrence of
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nightmares. It is not known whether there could be a lasting beneficial effect after drug
discontinuation.
6. Conclusion
Disturbances of sleep and arousal are significant symptoms of PTSD. Sleep disturbances have
also been implicated in the development of PTSD, although, at this time, there is no clear
consensus on the role these disturbances may play. As a diagnosis of PTSD may not be
determined for several months, there are little data concerning sleep architecture immediately
following the precipitating trauma. Thus, the potential role that stress-induced alterations in
sleep may play in the development of PTSD is poorly understood and the research questions
that could provide answers are inadequately articulated. Problems arise in part because work
in animal models, to date, has primarily been descriptive and hypotheses have been based on
the effects on sleep arising from experimental stressors that produce diverse effects on
subsequent sleep, and can be impacted by a variety of stressor parameters as well as differences
in subject vulnerability and resilience. This has led to difficulties in developing hypotheses
regarding the potential role of specific sleep states in mediating the outcomes of stress. Thus,
improved models of PTSD and improved understanding of the role sleep plays in mediating
stress-related psychopathology will be critical for developing more effective treatments for
PTSD and sleep symptomatology.
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